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SKIN TUMOURS AND SARCOMATA
INDUOED IN RATS BY

N_HYDROXY-2-ACETYLAMINOFLUOR&~E

Susan Gasteyer
(with C. M. Goodall MD)
1 q to \

(Reprinted from Nature, Vol. 211, No. 5056, p. 1422 only,
September 24, 1966)

Skin Tumours and Sarcomata induced in Rats
by N- Hydroxy-2-acetylaminofluorene
IT has been recently found that when 2-acetylaminofluorene (AAF) and several other carcinogenic amines
are administered to rats, N -hydroxylation of the compound occurs in ViV0 1 ,2. Using AAF, or several other
amines, it has been shown that the N-hydroxy metabolite
(N-OH-AAF) was a more active carcinogen than the
parent compound 3 •
It was therefore proposed that N-OH-AAF may be
the proximate carcinogen when AAF is administered to
rats 4 • In the course of some preliminary experiments we
have obtained additional evidence for this proposition.
Ten 8-week-old male MRC rats (210 g), were injected
once subcutaneously on the back with 5 mg of N-OHAAF dissolved in 0·5 ml. of warm olive oil. A week later
a shaved area lof interscapular skin was painted with a
2 per cent sohi,tion of N-OH-AAF in acetone, using a
fine hair brush. \ The rats were painted at first three times,
and later five times a week until the fortieth week, when
they had been treated 125 times. The animals were given
powdered laboratory chow and as much water as they
wanted to drink. Once a week they were weighed and
carefully inspected. At the twentieth week signs of skin
irritation and exudation appeared, and by the thirtythird week ulcers were present on most of the animals.
At the thirty-fifth week a crop of skin tumours suddenly
arose, and their progress was recorded weekly on graph
paper maps. One rat died of pneumonia at 25 weeks
without any other lesions, and the remaining nine rats
were killed when their tumours caused a decline in health.
A total of ten subcutaneous tumours occurred near the
site of the initial injection in seven of the nine surviving
rats. Eight of these were invasive fibrosarcomata, and
two were well differentiated, relatively benign, fibrous
tumours. Most of the subcutaneous tumours were a little
distant from the original "site of injection, no doubt as a
result of migration of the oily solution. The latent period
for the subcutaneous tumours varied from 20 to 44 weeks,
with a mean latency of 29·6 weeks.
The earliest skin tumour in the painted area was found
in the twenty-first week, and by the thirty-seventh week
all the surviving rats had tumours in the painted areas.
Six out of nine rats survived longer than 35 weeks, and
had a total of sixty skin tumou.rs. The number of skin
tumours on each rat increased steadily from the twentyfifth to the fifty -second week, when the final animal was
killed. Only four of the original sixty tumours regressed.
Of the fifty -six tumours which persisted, twenty (36 per
cent) showed a steady increase in size, and "\vere found on

histological examination to be invasive carcinomata. The
majority of the carcinomata were of the squamous type,
but a few were basal-cell carcinomata. The morphology
of the benign tumours was similar to that described for
mouse skin tumours 5 • Six rats had eight primary tumours
which arose at a distance from the painted areas, namely in
the Zymbal glands, breast, and lungs. One of the Zymbal
tumours and one of the breast tumours metastasized
widely.
The induction of malignant skin tumours in rats by
painting with N-OH-AAF was striking in view of the
usual refractoriness of rat skin to chemical carcinogens.
In rats painted with the parent compounds 2-AAF and
2-AF, skin tumours are very rare, and nearly always occur
at a distance from the painted area. The present results,
therefore, provide strong evidence for the local action of
N-OH-AAF as a direct carcinogen for rat skin and subcutaneous tissue, without metabolic modification. It is
considered that the single subcutaneous injection at the
beginning of the experiment could not have much influenced the r~sponse of the skin. The experiments are
being' repeatea and skin tumours have alreflrly been
obtained by p~inting alone. The occurrence of sarcomata
at or near the site of injection is also of interest in that they
appear to have been caused by a single injection, whereas
in work reported previously, multiple injections were
given 6 • The fact that combined treatment was given complicates this interpretation, however, because the occurrence of distant neoplasms indicates that there must have
been significant absorption either ofN-OH-AAF or of its
parent amines. Furthermore, it is impossible, at present,
to state what influence the painting may have had in the
appearance of the subcutaneous tumours.
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